Researchers from the Ohio State University have developed a rapid, multiplexed genotyping method to identify the single nucleotide polymorphisms (SNPs) that affect warfarin dose. The related report by Yang et al, “Rapid Genotyping of SNPs Influencing Warfarin Drug Response by SELDI-TOF Mass Spectrometry,” appears in the March 2010 issue of the Journal of Molecular Diagnostics. Warfarin is an anti-coagulant that is commonly used to prevent blood clots and embolism… (Source: Health News from Medical News Today)

Further information:

Article source

Related posts:

1. Personalized medicine in warfarin therapy
2. Argos Therapeutics Presents Positive Phase 2 Data Of Its Arcelis™ Personalized Immunotherapy Platform In Metastatic RCC At ASCO GU Symposium
3. Promising New Smoking Cessation Therapy
4. Superficial thrombosis linked to DVT and PE risk
5. Book Clubs For Doctors Show Human Side Of Medicine